- Twisted Sister Makeup Collection Launched by Rock and Roll Beauty
- Fans Primed To Offer Deion Sanders Lucrative Deal To Stay At Jsu
- Award-Winning Artists Celebrate the Continued Success of Education Through Music-Los Angeles at their Gala on Nov 30th
- Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency.
- The Synapse Medicine medication reconciliation tool will be deployed through an integration with the hospitals' current EPIC EHR workflow.
- The study also has potential to provide improvements to medication regimen appropriateness which helps reduce risk of ADEs in hospital and after discharge.
NEW YORK, Oct. 6, 2022 /PRNewswire/ -- Synapse Medicine, a leader in intelligent medication decision technology, announced today it has initiated a clinical study with Brigham and Women's Hospital, Boston, MA and the Vanderbilt University Medical Center, Nashville, TN to measure the benefits and efficacy of its clinical decision support solution and its medication reconciliation software in a hospital setting. The principal investigator is Dr. Jeffrey L. Schnipper, MD, MPH, MHM, of the Brigham's Division of General Internal Medicine and Primary Care and the Hospital Medicine Unit, and Professor of Medicine at Harvard Medical School.
The study, "Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency: A Hybrid Type 2 Implementation Study," engages hospital pharmacists at two study sites who round with general medicine service teams and approve inpatient medications. Participants will use Synapse Medicine point-of-care tools to analyze drug-related risks and optimize medication appropriateness. They will also perform medication reconciliation for newly admitted patients. The study will measure the usability of Synapse Medicine AI-driven clinical decision support and medication reconciliation tools quantitatively and qualitatively to determine their impact.
More on iSports Wire
- Sports Complex in New Ulm, Minnesota
- America's Boating Channel Will Highlight NASBLA Videos on Smart TV
- Inaugural North American Agrivoltaics Conference Seeks to Ignite Dual-Use Solar Renaissance
- InterMountain Management Selected to Manage Home2 Suites Avondale, AZ
- Jake The Snake joins I Only Touch Greatness Podcast
Leveraging real-time data for medication regimen appropriateness
Healthcare systems have long been challenged by the task of drug regimen optimization, a critical aspect in a patient's continuity of care. An inaccurate medication history or inappropriate drug therapy can burden care-providers' efficiency, delay treatment, put patients at risk for preventable adverse drug events (ADEs), and contribute to higher readmission rates. Hospital-related ADEs are frequent and dangerous, and their management has been estimated to cost US$28 billion annually.1
"Hospitalized patients often come to us on suboptimal medication regimens, especially too many medications. But we also encounter medications that react with each other, incorrect doses based on their kidney function, or medications that are inappropriate based on their many medical conditions," said Schnipper. "At the same time that we are treating patients' acute medical conditions, we also owe it to them to address these longer-standing medication issues and make sure we don't introduce any new medication-related problems before they return home."
Technology-based clinical decision support creates efficiencies and improves patient outcomes
"Optimizing a patient's medication regimen can be a time-consuming and complicated process, but it is fundamental to ensuring patient safety and therapeutic success," shared Dr. Clement Goehrs, Synapse Medicine CEO and Co-Founder. "Collaborating with Brigham and Women's Hospital and Vanderbilt University Medical Center allows us to demonstrate how our medication decision support technology improves accuracy and streamlines processes creating more time for actual patient care and bringing value to all stakeholders."
More on iSports Wire
- Pikmykid Announces Cutting Edge School Emergency Reunification Tool
- Dr. Amy L. Stark Debuts New Children's Book You Are More Than
- Global K9 Protection Group Marks Fourth Anniversary of 3PK9 Program
- Slick Cash Loan Offers Quick Personal Loans Even For Bad Credit Scores Across USA
- FirstLight Home Care Unveils Newly Designed Website
Synapse Medicine solutions are built on a technology platform that uses machine learning and natural language processing. It combines real-time drug knowledge with clinical data to detect potential medication risks and discrepancies that can lead to ADEs. The suite of clinical decision support tools enables healthcare professionals to provide enhanced personalized care for patients. The study will evaluate the prescription analysis, drug monograph and medication reconciliation solutions for efficiency and accuracy.
About Synapse Medicine
At Synapse Medicine, we believe in medication success, and are dedicated to making it possible for everyone.
To achieve this goal, we have built an extensive, global medication knowledge base using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey.
At Synapse Medicine, we are working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today's medication regimens into tomorrow's medication success.
- Weiss, A.J., Freeman, W.J., Heslin, K.C. and Barrett, M.L., 2018. Adverse drug events in US hospitals, 2010 versus 2014. HCUP Statistical Brief, 234.
Media contact: [email protected], +33 (0)5 56 35 50 87
Logo - https://mma.prnewswire.com/media/1914883/Synapse_Medicine_Logo.jpg
SOURCE Synapse Medicine
Latest on iSports Wire
- The East TOKYO Festival of Light launches in Tokyo, Presented by Tobu Railway Group
- Yida Gao and Shima Capital Invest in Web3 Gaming Startup Midnight
- Play time for edge computing is over—full scale deployments in 2023, predicts IOTech
- New consultancy launches to address poor communication within digital transformation projects
- Entertainer Sidow Sobrino Celebrates his 47th Birthday on December 1st
- Pickleball Champ Regina Goldberg Joins The Hunters Run Professional Team As Its New Pickleball Director
- National Minority Health Association Selected by Chan Zuckerberg Initiative for Grant
- KiwiQA, Australia based testing major, launches KiwiQA.io
- National Lacrosse League Announces Playoff Format and Playoff Schedule For 2022-23 Season
- NFL Coaches, Former Players Across Eight Teams To Support First Campaign Honoring Coach Greg Knapp
- Barcoding, Inc. Joins Zebra Technologies' PartnerConnect Mobile Robotics Specialization
- Advantage Anywhere Launches a Joint Venture and Licensing Partner Program for the Senior Living Industry
- Sojazzie Home Girl of Delgado Realty & Real African Art Gallery's Home For The Holidays Give Back
- Jason Halbert Exits Apollo Health Products to Expand 3Back Group
- Ken W. Stone Joins Talent Concierge®
- Netberg launches Aurora 810 platform for next-generation networks
- Charlotte Company Buys Unpaid Judgments in Mecklenburg and Iredell County
- Must Visit! New Restaurant in Kew Gardens, Queens NY - Love's Kitchen
- What You Need to Know: 2022 FIFA World Cup
- The Secret to Moving to London from the USA